Relief from Allergic Asthma in Just Three Years – Counsel & Heal


TopNews Arab Emirates

Relief from Allergic Asthma in Just Three Years
Counsel & Heal
Although there is no complete cure for childhood respiratory allergies, like dust mite induced allergies and asthma, researchers say that they now have a long term control for the allergy that can bring it under control just three years of allergy
Now, there's long-term control of allergic asthmaTimes of India
Allergic Asthma Probably Needs Three-Year TreatmentTopNews Arab Emirates
Administering immunotherapy for three years can reduce allergies, asthma in News-Medical.net
Tulsa World
all 15 news articles »

View full post on asthma – Google News

NIH study says no detectable difference in asthma control across three … – pharmabiz.com

NIH study says no detectable difference in asthma control across three
pharmabiz.com
The National Institutes of Health (NIH) has conducted a study comparing three common approaches to periodically adjust the dosage of inhaled corticosteroids (ICS) for people with mild asthma found no detectable differences in how often a person's

View full post on asthma – Google News

No Significant Difference in Asthma Control Across Three Approaches to Adjust … – eNews Park Forest

No Significant Difference in Asthma Control Across Three Approaches to Adjust
eNews Park Forest
A study comparing three common approaches to periodically adjust the dosage of inhaled corticosteroids (ICS) for people with mild asthma has found no detectable differences in how often a person's asthma worsened. The methods examined in this study

View full post on asthma – Google News

No significant difference in asthma control across three approaches to adjust … – Pharmaceutical Processing

No significant difference in asthma control across three approaches to adjust
Pharmaceutical Processing
A study comparing three common approaches to periodically adjust the dosage of inhaled corticosteroids (ICS) for people with mild asthma has found no detectable differences in how often a person's asthma worsened. The methods examined in this study

and more »

View full post on asthma – Google News

Three Pulmatrix PUR118 clinical studies on COPD, asthma to be presented at … – News-Medical.net

Three Pulmatrix PUR118 clinical studies on COPD, asthma to be presented at
News-Medical.net
Pulmatrix, Inc., a clinical stage biotechnology company creating novel inhaled therapeutics, announced today that three posters on its lead iCALM™ therapeutic, the first treatment developed utilizing its iSPERSE™ inhaled drug platform, will be

and more »

View full post on asthma – Google News

Prenatal Exposure to Bisphenol A and Child Wheeze from Birth to Three Years.

Prenatal Exposure to Bisphenol A and Child Wheeze from Birth to Three Years.

Environ Health Perspect. 2012 Feb 14;

Authors: Spanier AJ, Kahn RS, Kunselman AR, Hornung R, Xu Y, Calafat AM, Lanphear BP

Abstract
Background: Bisphenol A (BPA), an endocrine disrupting chemical that is routinely detected in >90% of Americans, promotes experimental asthma in mice. The association of prenatal BPA exposure and wheeze has not been evaluated in humans. Objective: To examine the relationship between prenatal BPA exposure and wheeze in early childhood. Methods: We measured BPA concentrations in serial maternal urine samples from a prospective birth cohort of 398 mother-infant pairs and assessed parent-reported child wheeze every six months for three years. We used generalized estimating equations (GEE) with a logit link to evaluate the association of prenatal urinary BPA concentration with the dichotomous outcome wheeze (wheeze over the previous six months). Results: Data were available for 365 children; BPA was detected in 99% of maternal urine samples during pregnancy. In multivariable analysis, a 1-unit increase in log-transformed creatinine-standardized mean prenatal urinary BPA concentration was not significantly associated with child wheeze from birth to three years of age, but there was an interaction of BPA concentration with time (p=0.003). Mean prenatal BPA above versus below the median was positively associated with wheeze at age six months [adjusted odds ratio (AOR) 2.3 (95% CI: 1.3, 4.1)], but not at three years (AOR=0.6, 95% CI: 0.3, 1.1). In secondary analyses evaluating associations of each prenatal BPA concentration separately, urinary BPA concentrations measured at 16 weeks gestation were associated with wheeze (AOR 1.2, 95% CI 1.0, 1.5), but not BPA concentrations at 26 weeks of gestation or at birth. Conclusions: Mean prenatal BPA was associated with increased odds of wheeze in early life, and the effect diminished over time. Evaluating exposure at each prenatal time point demonstrated an association between wheeze from six months to three years and log-transformed BPA concentration at 16 weeks gestation only.

PMID: 22334053 [PubMed – as supplied by publisher]

View full post on pubmed: asthma